HOME >> MEDICINE >> NEWS
Neuroscience and Psychiatry: NIMH Sponsors

The National Institute of Mental Health (NIMH) is sponsoring a symposium with scientific presentations in honor of Richard Jed Wyatt, M.D., a researcher at the National Institutes of Health (NIH) for 32 years and currently chief of the Neuropsychiatry Branch at NIMH The event will be held Wednesday, May 30, 2001, from 9-12am and 1:30-5pm, at Natcher Auditorium on the NIH campus in Bethesda, Maryland,. The event is open to the public.

Distinguished speakers will speak on topics of interest to Dr. Wyatt, throughout his career. Morning speakers include:

  • Solomon H. Snyder, M.D., Director, Department of neuroscience, Johns Hopkins Medical School, on "Forty Years of Neurotransmitters",
  • Patricia Goldman-Rakic, Ph.D., Professor of Neurobiology, Yale University, on "Microcircuitry of Cognition",
  • Barry Hoffer, M.D., Ph.D., Scientific Director, National Institute on Drug Abuse, on "Neural Transplantation - Deja-vu All Over Again",
  • Floyd Bloom, M.D., CEO, Neurome, Inc., on "Neuromics: How Genome Details Will Impact Neurosciences".

The afternoon will be comprised of short talks by scientists who served as fellows in Wyatt's laboratory over the years. They include: Daniel Weinberger, M.D., chief, NIMH Clinical Brain disorders Branch (CBDB); Joel Kleinman, M.D., NIMH CBDB; Karen Berman, NIMH CBDB; Lynn DeLisi, M.D., State University of New York, Stony Brook; Steve Potkin, M.D., University of California, Irvine; William Freed, Ph.D., NIDA; Jack Grebb, M.D., Janssen Research Foundation; and Daniel Luchins, M.D., University of Chicago.

"Richard Wyatt's lab has been the pioneer in translational research in psychiatry at the NIMH," noted Weinberger. "It provided a model for interactions between basic and clinical scientists focused around a common program goal: to understand the biology of schizophrenia. His l
'"/>

Contact: Marilyn Weeks or Rayford Kytle
rk94a@nih.gov
301-443-4536
NIH/National Institute of Mental Health
20-May-2001


Page: 1 2

Related medicine news :

1. News tips from the Journal of Neuroscience
2. News tips from the Journal of Neuroscience
3. News tips from the Journal of Neuroscience
4. News tips from the Journal of Neuroscience
5. News Tips from the Journal of Neuroscience
6. News tips from the Journal of Neuroscience
7. News tips from the Journal of Neuroscience
8. News tips from the Journal of Neuroscience
9. News tips from the Journal of Neuroscience
10. News tips from the Journal of Neuroscience
11. News tips from the Journal of Neuroscience

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Neuroscience and Psychiatry NIMH Sponsors

(Date:5/21/2013)... Spring is the perfect time to ... filled with whole foods to weather perfect for outdoor ... season the nutrition experts at Brilliant Nutrition highlight five ... , 1. Eating Locally, With the abundance of fresh ... and explore, spring is a great time to take ...
(Date:5/21/2013)... Standard advice for mattress shoppers often consists ... given industry’s less than exceptional satisfaction ratings and the ... Consumer Mattress Reports sets out to revise this advice ... .” , This article addresses several components of the ... not be readily apparent to many shoppers. From prices ...
(Date:5/21/2013)... Patients of Dr. Michael Shenk and Dr. Judd Shenk ... gum disease and would like permanent tooth replacements now have ... laser gum surgery. Gum disease must be treated prior ... of all tooth replacement options. , The Laser Assisted ... by the Food and Drug Administration (FDA) that greatly improves ...
(Date:5/21/2013)... analogues (PGAs), drugs which lower intraocular pressure, are often ... but their use is not without risks. PGAs have ... eye color and other side effects. Now a new ... and lower eyelid drooping and other issues that can ... PLOS ONE . , Researchers from the Massachusetts Eye ...
(Date:5/21/2013)... 2013 HealthSmart continues to grow through ... has required the hiring of new talent in several ... to announce that Dawn Powell has joined the organization ... Director of Account Management in the Central Region and ... Texas. With extensive client management, employee benefits, and product ...
Breaking Medicine News(10 mins):Health News:Brilliant Nutrition Offers 5 Ways to Live Healthier and Inspired this Spring 2Health News:Brilliant Nutrition Offers 5 Ways to Live Healthier and Inspired this Spring 3Health News:Choosing the Best Mattress Simplified in Consumer Mattress Reports’ Latest Article 2Health News:Shenk Dental Care Stimulates Bone Growth for Gum Disease Patients Seeking Dental Implants with Laser Gum Surgery in Atlanta, GA 2Health News:Glaucoma drug can cause droopy eyelids 2Health News:New Talent Joins the HealthSmart Account Management Team 2
(Date:5/21/2013)... May 21, 2013 BioElectronics Corp. (PINKSHEETS: ... electronic devices, announced that CEO, Andrew ... the FDA,s Medical Advisory Committee, Orthopedic and Rehabilitation ... for over the counter sales. "It,s ... medical device classification schema," Whelan said.  "While the ...
(Date:5/21/2013)... TARRYTOWN, N.Y. , May 21, 2013 ... Inc. (NASDAQ: REGN) today announced that the New ... Phase 2a study results of dupilumab (SAR231893/REGN668) in patients ... antibody targeting the alpha subunit of the interleukin 4 ... and IL-13, drivers of Th2 (Type 2 helper T ...
(Date:5/21/2013)... 2013 U.S. spending on specialty prescription drugs ... as cancer, multiple sclerosis and rheumatoid arthritis — is ... 2015, according to a forecast released today by Express ... ) "As we see what,s on ... to act so they can continue to offer an ...
Breaking Medicine Technology:BioElectronics Presents FDA Reclassification Panel 2BioElectronics Presents FDA Reclassification Panel 3Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 2Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 3Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 4Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 5Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 6Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 7U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 2U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 3U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 4U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 5
Cached News: